Spring Bank Pharmaceuticals, Inc. Human Resources Contracts & Agreements
26 Contracts & Agreements
- Bonus & Incentive Agreements (14 contracts)
- Compensation Agreements (4)
- Consulting Agreements (3)
- Employment Agreements (3)
- Retention Agreements (1)
- Transition Agreements (1)
- Employment Agreement Amendment, dated April 6, 2022 by and between F-star Therapeutics, Inc and Louis Kayitalire M.D (Filed With SEC on May 10, 2022)
- Addendum to the Indefinite-Term Employment Contract, dated as of June 25, 2021, by and between F-star Therapeutics, Inc. and Louis Kayitalire (Filed With SEC on May 10, 2022)
- Consulting Agreement Amendment, dated April 6, 2022 by and between F-star Therapeutics, Inc and Darlene Deptula-Hicks (Filed With SEC on May 10, 2022)
- Form of Restricted Share Unit Grant Notice and Agreement under the 2019 Equity Incentive Plan (Filed With SEC on March 15, 2022)
- Form of Performance Share Unit Grant Notice and Agreement under the 2019 Equity Incentive Plan (Filed With SEC on March 15, 2022)
- Form of Restricted Share Grant Notice and Agreement under the 2019 Equity Incentive Plan (Filed With SEC on March 15, 2022)
- Form of Option Agreement under the 2019 Equity Incentive Plan (Filed With SEC on March 15, 2022)
- Consulting Agreement, dated as of August 1, 2021, by and between F-star Therapeutics LLC and Darlene Deptula-Hicks (Filed With SEC on March 15, 2022)
- Non-Employee Director Compensation Policy (Filed With SEC on March 30, 2021)
- Employment Agreement, dated as of July 24, 2020, by and between F-star Therapeutics LLC and Louis Kayitalire, M.D (Filed With SEC on November 20, 2020)
- Consulting Agreement, dated as of May 1, 2019, by and between F-star Therapeutics LLC and Darlene Deptula-Hicks (Filed With SEC on November 20, 2020)
- SPRING BANK PHARMACEUTICALS, INC. RETENTION AND BONUS AWARD AGREEMENT (Filed With SEC on November 3, 2020)
- SPRING BANK PHARMACEUTICALS, INC. RETENTION AND BONUS AWARD AGREEMENT (Filed With SEC on November 3, 2020)
- Spring Bank Pharmaceuticals, Inc. Amended and Restated 2015 Stock Incentive Plan (Filed With SEC on June 25, 2020)
- Form of Retention Agreement (Filed With SEC on May 7, 2020)
- Amended and Restated Non-Employee Director Compensation Policy, effective January 1, 2019 (Filed With SEC on March 11, 2019)
- Form of Performance-Based Restricted Stock Unit Agreement under 2015 Stock Incentive Plan (Filed With SEC on March 11, 2019)
- Spring Bank Pharmaceuticals, Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on October 25, 2018)
- Spring Bank Pharmaceuticals, Inc. Amended and Restated 2015 Stock Incentive Plan (Filed With SEC on June 19, 2018)
- SPRING BANK PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Effective as of February 9, 2017) (Filed With SEC on February 14, 2017)
- TRANSITION AGREEMENT (Filed With SEC on January 5, 2016)
- SPRING BANK PHARMACEUTICALS, INC. INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on January 5, 2016)
- SPRING BANK PHARMACEUTICALS, INC. 2015 STOCK INCENTIVE PLAN (Filed With SEC on January 5, 2016)
- SPRING BANK PHARMACEUTICALS, INC. Nonstatutory Stock Option Agreement Granted Under 2014 Stock Incentive Plan (Filed With SEC on January 5, 2016)
- SPRING BANK PHARMACEUTICALS, INC. Incentive Stock Option Agreement Granted Under 2014 Stock Incentive Plan (Filed With SEC on January 5, 2016)
- SPRING BANK PHARMACEUTICALS, INC. 2014 STOCK INCENTIVE PLAN (Filed With SEC on January 5, 2016)
